
Global Gabapentin Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 (Based on 2020 COVID-19 Worldwide Spread)
The Gabapentin Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The Gabapentin market is expected to grow from USD X.X million in 2021 to USD X.X million by 2027, at a CAGR of X.X% during the forecast period. The global Gabapentin market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Gabapentin market. The report focuses on well-known providers in the global Gabapentin industry, market segments, competition, and the macro environment.
Under COVID-19 Outbreak, how the Gabapentin Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
Key players in the global Gabapentin market covered in Chapter 4:
Jiangsu Enhua
Actavis
Sailike
Jiangsu Hengrui
Glenmark
Pfizer
Novartis
GSK
In Chapter 11 and 13.3, on the basis of types, the Gabapentin market from 2016 to 2027 is primarily split into:
Capsule
Tablet
In Chapter 12 and 13.4, on the basis of applications, the Gabapentin market from 2016 to 2027 covers:
Seizures
Restless Legs Syndrome
Nerve Pain
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2016-2027) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2021-2027
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Gabapentin Market Share by Type (2021-2027)
1.5.2 Capsule
1.5.3 Tablet
1.6 Market by Application
1.6.1 Global Gabapentin Market Share by Application (2021-2027)
1.6.2 Seizures
1.6.3 Restless Legs Syndrome
1.6.4 Nerve Pain
1.7 Gabapentin Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Gabapentin Industry Development
2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19
3 Value Chain of Gabapentin Market
3.1 Value Chain Status
3.2 Gabapentin Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Gabapentin
3.2.3 Labor Cost of Gabapentin
3.2.3.1 Labor Cost of Gabapentin Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19
4 Players Profiles
4.1 Jiangsu Enhua
4.1.1 Jiangsu Enhua Basic Information
4.1.2 Gabapentin Product Profiles, Application and Specification
4.1.3 Jiangsu Enhua Gabapentin Market Performance (2016-2021)
4.1.4 Jiangsu Enhua Business Overview
4.2 Actavis
4.2.1 Actavis Basic Information
4.2.2 Gabapentin Product Profiles, Application and Specification
4.2.3 Actavis Gabapentin Market Performance (2016-2021)
4.2.4 Actavis Business Overview
4.3 Sailike
4.3.1 Sailike Basic Information
4.3.2 Gabapentin Product Profiles, Application and Specification
4.3.3 Sailike Gabapentin Market Performance (2016-2021)
4.3.4 Sailike Business Overview
4.4 Jiangsu Hengrui
4.4.1 Jiangsu Hengrui Basic Information
4.4.2 Gabapentin Product Profiles, Application and Specification
4.4.3 Jiangsu Hengrui Gabapentin Market Performance (2016-2021)
4.4.4 Jiangsu Hengrui Business Overview
4.5 Glenmark
4.5.1 Glenmark Basic Information
4.5.2 Gabapentin Product Profiles, Application and Specification
4.5.3 Glenmark Gabapentin Market Performance (2016-2021)
4.5.4 Glenmark Business Overview
4.6 Pfizer
4.6.1 Pfizer Basic Information
4.6.2 Gabapentin Product Profiles, Application and Specification
4.6.3 Pfizer Gabapentin Market Performance (2016-2021)
4.6.4 Pfizer Business Overview
4.7 Novartis
4.7.1 Novartis Basic Information
4.7.2 Gabapentin Product Profiles, Application and Specification
4.7.3 Novartis Gabapentin Market Performance (2016-2021)
4.7.4 Novartis Business Overview
4.8 GSK
4.8.1 GSK Basic Information
4.8.2 Gabapentin Product Profiles, Application and Specification
4.8.3 GSK Gabapentin Market Performance (2016-2021)
4.8.4 GSK Business Overview
5 Global Gabapentin Market Analysis by Regions
5.1 Global Gabapentin Sales, Revenue and Market Share by Regions
5.1.1 Global Gabapentin Sales by Regions (2016-2021)
5.1.2 Global Gabapentin Revenue by Regions (2016-2021)
5.2 North America Gabapentin Sales and Growth Rate (2016-2021)
5.3 Europe Gabapentin Sales and Growth Rate (2016-2021)
5.4 Asia-Pacific Gabapentin Sales and Growth Rate (2016-2021)
5.5 Middle East and Africa Gabapentin Sales and Growth Rate (2016-2021)
5.6 South America Gabapentin Sales and Growth Rate (2016-2021)
6 North America Gabapentin Market Analysis by Countries
6.1 North America Gabapentin Sales, Revenue and Market Share by Countries
6.1.1 North America Gabapentin Sales by Countries (2016-2021)
6.1.2 North America Gabapentin Revenue by Countries (2016-2021)
6.1.3 North America Gabapentin Market Under COVID-19
6.2 United States Gabapentin Sales and Growth Rate (2016-2021)
6.2.1 United States Gabapentin Market Under COVID-19
6.3 Canada Gabapentin Sales and Growth Rate (2016-2021)
6.4 Mexico Gabapentin Sales and Growth Rate (2016-2021)
7 Europe Gabapentin Market Analysis by Countries
7.1 Europe Gabapentin Sales, Revenue and Market Share by Countries
7.1.1 Europe Gabapentin Sales by Countries (2016-2021)
7.1.2 Europe Gabapentin Revenue by Countries (2016-2021)
7.1.3 Europe Gabapentin Market Under COVID-19
7.2 Germany Gabapentin Sales and Growth Rate (2016-2021)
7.2.1 Germany Gabapentin Market Under COVID-19
7.3 UK Gabapentin Sales and Growth Rate (2016-2021)
7.3.1 UK Gabapentin Market Under COVID-19
7.4 France Gabapentin Sales and Growth Rate (2016-2021)
7.4.1 France Gabapentin Market Under COVID-19
7.5 Italy Gabapentin Sales and Growth Rate (2016-2021)
7.5.1 Italy Gabapentin Market Under COVID-19
7.6 Spain Gabapentin Sales and Growth Rate (2016-2021)
7.6.1 Spain Gabapentin Market Under COVID-19
7.7 Russia Gabapentin Sales and Growth Rate (2016-2021)
7.7.1 Russia Gabapentin Market Under COVID-19
8 Asia-Pacific Gabapentin Market Analysis by Countries
8.1 Asia-Pacific Gabapentin Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Gabapentin Sales by Countries (2016-2021)
8.1.2 Asia-Pacific Gabapentin Revenue by Countries (2016-2021)
8.1.3 Asia-Pacific Gabapentin Market Under COVID-19
8.2 China Gabapentin Sales and Growth Rate (2016-2021)
8.2.1 China Gabapentin Market Under COVID-19
8.3 Japan Gabapentin Sales and Growth Rate (2016-2021)
8.3.1 Japan Gabapentin Market Under COVID-19
8.4 South Korea Gabapentin Sales and Growth Rate (2016-2021)
8.4.1 South Korea Gabapentin Market Under COVID-19
8.5 Australia Gabapentin Sales and Growth Rate (2016-2021)
8.6 India Gabapentin Sales and Growth Rate (2016-2021)
8.6.1 India Gabapentin Market Under COVID-19
8.7 Southeast Asia Gabapentin Sales and Growth Rate (2016-2021)
8.7.1 Southeast Asia Gabapentin Market Under COVID-19
9 Middle East and Africa Gabapentin Market Analysis by Countries
9.1 Middle East and Africa Gabapentin Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Gabapentin Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Gabapentin Revenue by Countries (2016-2021)
9.1.3 Middle East and Africa Gabapentin Market Under COVID-19
9.2 Saudi Arabia Gabapentin Sales and Growth Rate (2016-2021)
9.3 UAE Gabapentin Sales and Growth Rate (2016-2021)
9.4 Egypt Gabapentin Sales and Growth Rate (2016-2021)
9.5 Nigeria Gabapentin Sales and Growth Rate (2016-2021)
9.6 South Africa Gabapentin Sales and Growth Rate (2016-2021)
10 South America Gabapentin Market Analysis by Countries
10.1 South America Gabapentin Sales, Revenue and Market Share by Countries
10.1.1 South America Gabapentin Sales by Countries (2016-2021)
10.1.2 South America Gabapentin Revenue by Countries (2016-2021)
10.1.3 South America Gabapentin Market Under COVID-19
10.2 Brazil Gabapentin Sales and Growth Rate (2016-2021)
10.2.1 Brazil Gabapentin Market Under COVID-19
10.3 Argentina Gabapentin Sales and Growth Rate (2016-2021)
10.4 Columbia Gabapentin Sales and Growth Rate (2016-2021)
10.5 Chile Gabapentin Sales and Growth Rate (2016-2021)
11 Global Gabapentin Market Segment by Types
11.1 Global Gabapentin Sales, Revenue and Market Share by Types (2016-2021)
11.1.1 Global Gabapentin Sales and Market Share by Types (2016-2021)
11.1.2 Global Gabapentin Revenue and Market Share by Types (2016-2021)
11.2 Capsule Sales and Price (2016-2021)
11.3 Tablet Sales and Price (2016-2021)
12 Global Gabapentin Market Segment by Applications
12.1 Global Gabapentin Sales, Revenue and Market Share by Applications (2016-2021)
12.1.1 Global Gabapentin Sales and Market Share by Applications (2016-2021)
12.1.2 Global Gabapentin Revenue and Market Share by Applications (2016-2021)
12.2 Seizures Sales, Revenue and Growth Rate (2016-2021)
12.3 Restless Legs Syndrome Sales, Revenue and Growth Rate (2016-2021)
12.4 Nerve Pain Sales, Revenue and Growth Rate (2016-2021)
13 Gabapentin Market Forecast by Regions (2021-2027)
13.1 Global Gabapentin Sales, Revenue and Growth Rate (2021-2027)
13.2 Gabapentin Market Forecast by Regions (2021-2027)
13.2.1 North America Gabapentin Market Forecast (2021-2027)
13.2.2 Europe Gabapentin Market Forecast (2021-2027)
13.2.3 Asia-Pacific Gabapentin Market Forecast (2021-2027)
13.2.4 Middle East and Africa Gabapentin Market Forecast (2021-2027)
13.2.5 South America Gabapentin Market Forecast (2021-2027)
13.3 Gabapentin Market Forecast by Types (2021-2027)
13.4 Gabapentin Market Forecast by Applications (2021-2027)
13.5 Gabapentin Market Forecast Under COVID-19
14 Appendix
14.1 Methodology
14.2 Research Data Source
List of Tables and Figures
Table Global Gabapentin Market Size Growth Rate by Type (2021-2027)
Figure Global Gabapentin Market Share by Type in 2020 & 2026
Figure Capsule Features
Figure Tablet Features
Table Global Gabapentin Market Size Growth by Application (2021-2027)
Figure Global Gabapentin Market Share by Application in 2020 & 2026
Figure Seizures Description
Figure Restless Legs Syndrome Description
Figure Nerve Pain Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Gabapentin Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Gabapentin Market Size and Growth Rate 2016-2027
Table Industry News
Table Industry Policies
Figure Value Chain Status of Gabapentin
Figure Production Process of Gabapentin
Figure Manufacturing Cost Structure of Gabapentin
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Jiangsu Enhua Profile
Table Jiangsu Enhua Production, Value, Price, Gross Margin 2016-2021
Table Actavis Profile
Table Actavis Production, Value, Price, Gross Margin 2016-2021
Table Sailike Profile
Table Sailike Production, Value, Price, Gross Margin 2016-2021
Table Jiangsu Hengrui Profile
Table Jiangsu Hengrui Production, Value, Price, Gross Margin 2016-2021
Table Glenmark Profile
Table Glenmark Production, Value, Price, Gross Margin 2016-2021
Table Pfizer Profile
Table Pfizer Production, Value, Price, Gross Margin 2016-2021
Table Novartis Profile
Table Novartis Production, Value, Price, Gross Margin 2016-2021
Table GSK Profile
Table GSK Production, Value, Price, Gross Margin 2016-2021
Figure Global Gabapentin Sales and Growth Rate (2016-2021)
Figure Global Gabapentin Revenue ($) and Growth (2016-2021)
Table Global Gabapentin Sales by Regions (2016-2021)
Table Global Gabapentin Sales Market Share by Regions (2016-2021)
Table Global Gabapentin Revenue ($) by Regions (2016-2021)
Table Global Gabapentin Revenue Market Share by Regions (2016-2021)
Table Global Gabapentin Revenue Market Share by Regions in 2016
Table Global Gabapentin Revenue Market Share by Regions in 2020
Figure North America Gabapentin Sales and Growth Rate (2016-2021)
Figure Europe Gabapentin Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Gabapentin Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Gabapentin Sales and Growth Rate (2016-2021)
Figure South America Gabapentin Sales and Growth Rate (2016-2021)
Figure North America Gabapentin Revenue ($) and Growth (2016-2021)
Table North America Gabapentin Sales by Countries (2016-2021)
Table North America Gabapentin Sales Market Share by Countries (2016-2021)
Figure North America Gabapentin Sales Market Share by Countries in 2016
Figure United States Gabapentin Sales and Growth Rate (2016-2021)
Figure Canada Gabapentin Sales and Growth Rate (2016-2021)
Figure Mexico Gabapentin Sales and Growth (2016-2021)
Figure Europe Gabapentin Revenue ($) Growth (2016-2021)
Table Europe Gabapentin Sales by Countries (2016-2021)
Table Europe Gabapentin Sales Market Share by Countries (2016-2021)
Figure Germany Gabapentin Sales and Growth Rate (2016-2021)
Figure UK Gabapentin Sales and Growth Rate (2016-2021)
Figure France Gabapentin Sales and Growth Rate (2016-2021)
Figure Italy Gabapentin Sales and Growth Rate (2016-2021)
Figure Spain Gabapentin Sales and Growth Rate (2016-2021)
Figure Russia Gabapentin Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Gabapentin Revenue ($) and Growth (2016-2021)
Table Asia-Pacific Gabapentin Sales by Countries (2016-2021)
Table Asia-Pacific Gabapentin Sales Market Share by Countries (2016-2021)
Figure China Gabapentin Sales and Growth Rate (2016-2021)
Figure Japan Gabapentin Sales and Growth Rate (2016-2021)
Figure South Korea Gabapentin Sales and Growth Rate (2016-2021)
Figure Australia Gabapentin Sales and Growth Rate (2016-2021)
Figure India Gabapentin Sales and Growth Rate (2016-2021)
Figure Southeast Asia Gabapentin Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Gabapentin Revenue ($) and Growth (2016-2021)
Table Middle East and Africa Gabapentin Sales by Countries (2016-2021)
Table Middle East and Africa Gabapentin Sales Market Share by Countries (2016-2021)
Figure Saudi Arabia Gabapentin Sales and Growth Rate (2016-2021)
Figure UAE Gabapentin Sales and Growth Rate (2016-2021)
Figure Egypt Gabapentin Sales and Growth Rate (2016-2021)
Figure Nigeria Gabapentin Sales and Growth Rate (2016-2021)
Figure South Africa Gabapentin Sales and Growth Rate (2016-2021)
Figure South America Gabapentin Revenue ($) and Growth (2016-2021)
Figure Brazil Gabapentin Sales and Growth Rate (2016-2021)
Figure Argentina Gabapentin Sales and Growth Rate (2016-2021)
Figure Columbia Gabapentin Sales and Growth Rate (2016-2021)
Figure Chile Gabapentin Sales and Growth Rate (2016-2021)
Table Global Gabapentin Sales by Types (2016-2021)
Table Global Gabapentin Revenue ($) by Types (2016-2021)
Figure Global Capsule Sales and Growth Rate (2016-2021)
Figure Global Capsule Price (2016-2021)
Figure Global Tablet Sales and Growth Rate (2016-2021)
Figure Global Tablet Price (2016-2021)
Table Global Gabapentin Sales by Applications (2016-2021)
Table Global Gabapentin Sales Share by Applications (2016-2021)
Figure Global Seizures Sales and Growth Rate (2016-2021)
Figure Global Seizures Revenue and Growth Rate (2016-2021)
Figure Global Restless Legs Syndrome Sales and Growth Rate (2016-2021)
Figure Global Restless Legs Syndrome Revenue and Growth Rate (2016-2021)
Figure Global Nerve Pain Sales and Growth Rate (2016-2021)
Figure Global Nerve Pain Revenue and Growth Rate (2016-2021)
Figure Global Gabapentin Sales and Growth Rate (2021-2027)
Figure Global Gabapentin Revenue ($) and Growth Rate (2021-2027)
Table Global Gabapentin Sales Forecast by Regions (2021-2027)
Table Global Gabapentin Revenue Forecast by Regions (2021-2027)
Figure North America Gabapentin Sales Forecast (2021-2027)
Figure North America Gabapentin Revenue Forecast (2021-2027)
Figure Europe Gabapentin Sales Forecast (2021-2027)
Figure Europe Gabapentin Revenue Forecast (2021-2027)
Figure Asia-Pacific Gabapentin Sales Forecast (2021-2027)
Figure Asia-Pacific Gabapentin Revenue Forecast (2021-2027)
Figure Middle East and Africa Gabapentin Sales Forecast (2021-2027)
Figure Middle East and Africa Gabapentin Revenue Forecast (2021-2027)
Figure South America Gabapentin Sales Forecast (2021-2027)
Figure South America Gabapentin Revenue Forecast (2021-2027)
Table Global Gabapentin Sales Forecast by Types (2021-2027)
Table Global Gabapentin Sales Market Share Forecast by Types (2021-2027)
Table Global Gabapentin Revenue Market Share Forecast by Types (2021-2027)
Table Global Gabapentin Sales Market Share Forecast by Applications (2021-2027)
Table Global Gabapentin Revenue Forecast by Applications (2021-2027)
Table Global Gabapentin Revenue Market Share Forecast by Applications (2021-2027)
Research Methodology:
Gabapentin Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|